The DOI matches its Crossref record; 157 of the 157 references it cites were found in a registry or an index.
Cross‐presentation: underlying mechanisms and role in immune surveillance
Abstract
Summary: It was originally thought that a cell's major histocompatibility complex (MHC) class I molecules presented peptides derived exclusively from proteins synthesized by the cell itself. However, in some circumstances, antigens from the extracellular environment can be presented on MHC class I molecules and stimulate CD8+ T‐cell immunity, a process termed cross‐presentation. Cross‐presentation was originally discovered as an obscure phenomenon in transplantation immunity. However, it is now clear that it is a major mechanism by which the immune system monitors tissues and phagocytes for the presence of foreign antigen. Cross‐presentation is the only pathway by which the immune system can detect and respond to viral infections or mutations that exclusively occur in parenchymal cells rather than in bone marrow‐derived antigen‐presenting cells (APCs). Professional APCs, such as dendritic cells, are the principal cells endowed with the capacity to cross‐present antigens. In this process, the APCs acquire proteins from other tissue cells through endocytic mechanisms, especially phagocytosis or macropinocytosis. The internalized antigen can then be processed through at least two different mechanisms. In one pathway, the antigen is transferred from the phagosome into the cytosol, where it is hydrolyzed by proteasomes into oligopeptides that are then transported by the transporter associated with antigen processing to MHC class I molecules in the endoplasmic reticulum or phagosomes. In a second pathway, the antigen is cleaved into peptides by endosomal proteases, particularly cathepsin S, and bound by class I molecules probably in the endocytic compartment itself. Depending on the nature of the antigen, one or both of these pathways can contribute to cross‐presentation in vivo. The outcome of cross‐presentation can be either tolerance or immunity. Which of these outcomes occurs is thought to depend on whether antigens are acquired by themselves alone, leading to tolerance, or with immunostimulatory signals, leading to immunity. One source of such signals is from dying cells that release immunostimulatory ‘danger’ signals that promote the generation of immunity to their cellular antigens. In addition to the critical role of cross‐presentation in normal immune physiology, this pathway has considerable potential for being exploited for developing subunit vaccines that elicit both CD4+ and CD8+ T‐cell immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,820
The Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., & Goldberg, A. L. (1994) · Cell · doi:10.1016/s0092-8674(94)90462-6 · Cited by 2,524
Self-citationDendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
Albert, M. L., Sauter, B., & Bhardwaj, N. (1998) · Nature · doi:10.1038/32183 · Cited by 2,349
Mouse and human dendritic cell subtypes
Shortman, K., & Liu, Y.-J. (2002) · Nature Reviews Immunology · doi:10.1038/nri746 · Cited by 2,291
Jung, S., Unutmaz, D., Wong, P., Sano, G.-I., De los Santos, K., Sparwasser, T., Wu, S., Vuthoori, S., Ko, K., Zavala, F., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00365-5 · Cited by 1,773
Townsend, A. (1986) · Cell · doi:10.1016/0092-8674(86)90019-x · Cited by 1,699
Molecular identification of a danger signal that alerts the immune system to dying cells
Shi, Y., Evans, J. E., & Rock, K. L. (2003) · Nature · doi:10.1038/nature01991 · Cited by 1,684
Self-citationPlasmacytoid dendritic cells in immunity
Colonna, M., Trinchieri, G., & Liu, Y.-J. (2004) · Nature Immunology · doi:10.1038/ni1141 · Cited by 1,678
IPC: Professional Type 1 Interferon-Producing Cells and Plasmacytoid Dendritic Cell Precursors
Liu, Y.-J. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115633 · Cited by 1,625
A blast from the past: clearance of apoptotic cells regulates immune responses
Savill, J., Dransfield, I., Gregory, C., & Haslett, C. (2002) · Nature Reviews Immunology · doi:10.1038/nri957 · Cited by 1,574
THE UBIQUITIN SYSTEM FOR PROTEIN DEGRADATION
Hershko, A., & Ciechanover, A. (1992) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.61.070192.003553 · Cited by 1,410
Ubiquitin: structures, functions, mechanisms
Pickart, C. M., & Eddins, M. J. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.09.019 · Cited by 1,407
Cd8+ but Not Cd8− Dendritic Cells Cross-Prime Cytotoxic T Cells in Vivo
den Haan, J. M. M., Lehar, S. M., & Bevan, M. J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.12.1685 · Cited by 1,328
Basu, S., Binder, R. J., Suto, R., Anderson, K. M., & Srivastava, P. K. (2000) · International Immunology · doi:10.1093/intimm/12.11.1539 · Cited by 1,305
Introduction of soluble protein into the class I pathway of antigen processing and presentation
Moore, M. W., Carbone, F. R., & Bevan, M. J. (1988) · Cell · doi:10.1016/s0092-8674(88)91043-4 · Cited by 1,092
Roles of heat-shock proteins in innate and adaptive immunity.
Srivastava, P. (2002) · Nature reviews. Immunology · doi:10.1038/nri749 · Cited by 1,069 · cited 1×
“HSPs have been shown to induce DC maturation in vitro (144–148) to promote DC migration and to prime CTLs in vivo (28, 149, 150), and they have been considered the major source of endogenous adjuvant activity (151, 152).”
BackgroundRegulation of Phagosome Maturation by Signals from Toll-Like Receptors
Blander, J. M., & Medzhitov, R. (2004) · Science · doi:10.1126/science.1096158 · Cited by 991 · cited 1×
“Indeed, pathogens and innate signals have been shown to have effects on MHC class I biosynthesis (126) and phagosome maturation (127).”
BackgroundBevan, M. J. (1976) · The Journal of experimental medicine · doi:10.1084/jem.143.5.1283 · Cited by 956
DEGRADATION OF CELL PROTEINS AND THE GENERATION OF MHC CLASS I-PRESENTED PEPTIDES
Rock, K. L., & Goldberg, A. L. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.739 · Cited by 921
Self-citationDendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.
Boczkowski, D., Nair, S. K., Snyder, D., & Gilboa, E. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.465 · Cited by 915
A Phagosome-to-Cytosol Pathway for Exogenous Antigens Presented on MHC Class I Molecules
Kovacsovics-Bankowski, M., & Rock, K. L. (1995) · Science · doi:10.1126/science.7809629 · Cited by 884 · cited 6×
“In contrast, proteasome inhibitors did not block the ability of the APCs to present peptides that were produced directly in the cytosol from minigenes (74).”
BackgroundInfluentialSelf-citationCross-Presentation, Dendritic Cells, Tolerance and Immunity
Heath, W. R., & Carbone, F. R. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.47 · Cited by 882
Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules.
Shen, Z., Reznikoff, G., Dranoff, G., & Rock, K. L. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.6.2723 · Cited by 846
Self-citationA Mechanism for the Specific Immunogenicity of Heat Shock Protein-Chaperoned Peptides
Suto, R., & Srivastava, P. K. (1995) · Science · doi:10.1126/science.7545313 · Cited by 823
Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon
Le Bon, A., Etchart, N., Rossmann, C., Ashton, M., Hou, S., Gewert, D., Borrow, P., & Tough, D. F. (2003) · Nature Immunology · doi:10.1038/ni978 · Cited by 818
EMERGING ROLES FOR CYSTEINE PROTEASES IN HUMAN BIOLOGY
Chapman, H. A., Riese, R. J., & Shi, G.-P. (1997) · Annual Review of Physiology · doi:10.1146/annurev.physiol.59.1.63 · Cited by 786
ER–phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells
Guermonprez, P., Saveanu, L., Kleijmeer, M., Davoust, J., van Endert, P., & Amigorena, S. (2003) · Nature · doi:10.1038/nature01911 · Cited by 753
Cross‐presentation, dendritic cell subsets, and the generation of immunity to cellular antigens
Heath, W. R., Belz, G. T., Behrens, G. M. N., Smith, C. M., Forehan, S. P., Parish, I. A., Davey, G. M., Wilson, N. S., Carbone, F. R., & Villadangos, J. A. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00142.x · Cited by 735
Kurts, C., Kosaka, H., Carbone, F. R., Miller, J. F. A. P., & Heath, W. R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.2.239 · Cited by 706
Phagosomes are competent organelles for antigen cross-presentation
Houde, M., Bertholet, S., Gagnon, E., Brunet, S., Goyette, G., Laplante, A., Princiotta, M. F., Thibault, P., Sacks, D., & Desjardins, M. (2003) · Nature · doi:10.1038/nature01912 · Cited by 699
Endogenous ligands of Toll-like receptors
Tsan, M.-F., & Gao, B. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0304127 · Cited by 685
Endoplasmic Reticulum-Mediated Phagocytosis Is a Mechanism of Entry into Macrophages
Gagnon, E., Duclos, S., Rondeau, C., Chevet, E., Cameron, P. H., Steele-Mortimer, O., Paiement, J., Bergeron, J. J. M., & Desjardins, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00797-3 · Cited by 683
ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum
Serwold, T., Gonzalez, F., Kim, J., Jacob, R., & Shastri, N. (2002) · Nature · doi:10.1038/nature01074 · Cited by 628
Inaba, K., Turley, S., Yamaide, F., Iyoda, T., Mahnke, K., Inaba, M., Pack, M., Subklewe, M., Sauter, B., Sheff, D., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.11.2163 · Cited by 623
Heat shock protein 70-associated peptides elicit specific cancer immunity.
Udono, H., & Srivastava, P. K. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.4.1391 · Cited by 621
Phagocytic processing of bacterial antigens for class I MHC presentation to T cells
Pfeifer, J. D., Wick, M. J., Roberts, R. L., Findlay, K., Normark, S. J., & Harding, C. V. (1993) · Nature · doi:10.1038/361359a0 · Cited by 615 · cited 3×
“Consistent with these possibilities, vacuolar cross-presentation was reported to be insensitive to brefeldin A (BFA), which blocks exocytosis of proteins from the ER (68); however, this is a controversial finding.”
BackgroundANTIGEN PROCESSING AND PRESENTATION BY THE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX
York, I. A., & Rock, K. L. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.369 · Cited by 610
Self-citationKovacsovics-Bankowski, M., Clark, K., Benacerraf, B., & Rock, K. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.4942 · Cited by 591
Self-citationSigal, L. J., Crotty, S., Andino, R., & Rock, K. L. (1999) · Nature · doi:10.1038/18038 · Cited by 578
Self-citationThe Sizes of Peptides Generated from Protein by Mammalian 26 and 20 S Proteasomes
Kisselev, A. F., Akopian, T. N., Woo, K. M., & Goldberg, A. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.6.3363 · Cited by 573
Heat shock proteins transfer peptides during antigen processing and CTL priming
Srivastava, P., Udono, H., Blachere, N., & Li, Z. (1994) · Immunogenetics · doi:10.1007/bf00188611 · Cited by 569
Proteolysis, proteasomes and antigen presentation
Goldberg, A. L., & Rock, K. L. (1992) · Nature · doi:10.1038/357375a0 · Cited by 568
Self-citationEpidermal Viral Immunity Induced by CD8α + Dendritic Cells But Not by Langerhans Cells
Allan, R. S., Smith, C. M., Belz, G. T., van Lint, A. L., Wakim, L. M., Heath, W. R., & Carbone, F. R. (2003) · Science · doi:10.1126/science.1087576 · Cited by 567
Blachere, N. E., Li, Z., Chandawarkar, R. Y., Suto, R., Jaikaria, N. S., Basu, S., Udono, H., & Srivastava, P. K. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1315 · Cited by 556
Rodriguez, A., Regnault, A., Kleijmeer, M., Ricciardi-Castagnoli, P., & Amigorena, S. (1999) · Nature Cell Biology · doi:10.1038/14058 · Cited by 552
An IFN-γ–induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I–presented peptides
Saric, T., Chang, S.-C., Hattori, A., York, I. A., Markant, S., Rock, K. L., Tsujimoto, M., & Goldberg, A. L. (2002) · Nature Immunology · doi:10.1038/ni859 · Cited by 528
Self-citationER Quality Control: The Cytoplasmic Connection
Kopito, R. R. (1997) · Cell · doi:10.1016/s0092-8674(00)81881-4 · Cited by 518
York, I. A., Chang, S.-C., Saric, T., Keys, J. A., Favreau, J. M., Goldberg, A. L., & Rock, K. L. (2002) · Nature Immunology · doi:10.1038/ni860 · Cited by 511
Self-citationBEG, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02317-7 · Cited by 495
Cross-presentation in viral immunity and self-tolerance
Heath, W. R., & Carbone, F. R. (2001) · Nature Reviews Immunology · doi:10.1038/35100512 · Cited by 480
Belz, G. T., Behrens, G. M. N., Smith, C. M., Miller, J. F. A. P., Jones, C., Lejon, K., Fathman, C. G., Mueller, S. N., Shortman, K., Carbone, F. R., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020861 · Cited by 467
Messmer, D., Yang, H., Telusma, G., Knoll, F., Li, J., Messmer, B., Tracey, K. J., & Chiorazzi, N. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.307 · Cited by 447
Norbury, C. C., Hewlett, L. J., Prescott, A. R., Shastri, N., & Watts, C. (1995) · Immunity · doi:10.1016/1074-7613(95)90067-5 · Cited by 410
A new foreign policy: MHC class I molecules monitor the outside world
Rock, K. L. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80605-0 · Cited by 403
Self-citationClass I-restricted processing and presentation of exogenous cell-associated antigen in vivo.
Carbone, F. R., & Bevan, M. J. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.2.377 · Cited by 402
Gao, B., & Tsan, M.-F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208742200 · Cited by 396
Shen, L., Sigal, L. J., Boes, M., & Rock, K. L. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.004 · Cited by 391
Self-citationHarding, C. V., & Song, R. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.11.4925 · Cited by 383
Ackerman, A. L., Kyritsis, C., Tampé, R., & Cresswell, P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1735556100 · Cited by 383
Craiu, A., Gaczynska, M., Akopian, T., Gramm, C. F., Fenteany, G., Goldberg, A. L., & Rock, K. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.20.13437 · Cited by 382
Self-citationSingh-Jasuja, H., Scherer, H. U., Hilf, N., Arnold-Schild, D., Rammensee, H.-G., Toes, R. E. M., & Schild, H. (2000) · European Journal of Immunology · doi:10.1002/1521-4141(2000)30:18<2211::aid-immu2211>3.0.co;2-h · Cited by 380
Singh-Jasuja, H., Toes, R. E. M., Spee, P., Münz, C., Hilf, N., Schoenberger, S. P., Ricciardi-Castagnoli, P., Neefjes, J., Rammensee, H.-G., Arnold-Schild, D., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.11.1965 · Cited by 348
Goldberg, A. L., Cascio, P., Saric, T., & Rock, K. L. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(02)00098-6 · Cited by 345
Self-citationVisualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo
Norbury, C. C., Malide, D., Gibbs, J. S., Bennink, J. R., & Yewdell, J. W. (2002) · Nature Immunology · doi:10.1038/ni762 · Cited by 342
Presentation of Exogenous Antigen with Class I Major Histocompatibility Complex Molecules
Rock, K. L., Gamble, S., & Rothstein, L. (1990) · Science · doi:10.1126/science.2392683 · Cited by 334
Self-citationden Haan, J. M. M., & Bevan, M. J. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020295 · Cited by 326
Dendritic Cells Acquire Antigens from Live Cells for Cross-Presentation to CTL
Harshyne, L. A., Watkins, S. C., Gambotto, A., & Barratt-Boyes, S. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.3717 · Cited by 321
Kurts, C., Miller, J. F. A. P., Subramaniam, R. M., Carbone, F. R., & Heath, W. R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.409 · Cited by 309
Shi, G. P., Munger, J. S., Meara, J. P., Rich, D. H., & Chapman, H. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42513-6 · Cited by 308
Belz, G. T., Smith, C. M., Eichner, D., Shortman, K., Karupiah, G., Carbone, F. R., & Heath, W. R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.1996 · Cited by 300
Reits, E., Griekspoor, A., Neijssen, J., Groothuis, T., Jalink, K., van Veelen, P., Janssen, H., Calafat, J., Drijfhout, J. W., & Neefjes, J. (2003) · Immunity · doi:10.1016/s1074-7613(02)00511-3 · Cited by 299
Reis e Sousa, C., & Germain, R. N. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.3.841 · Cited by 296
Binder, R. J., & Srivastava, P. K. (2005) · Nature Immunology · doi:10.1038/ni1201 · Cited by 295
Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity
Falo, L. D., Kovacsovics-Bankowski, M., Thompson, K., & Rock, K. L. (1995) · Nature Medicine · doi:10.1038/nm0795-649 · Cited by 289
Self-citationCD8 + T Cell Cross-Priming via Transfer of Proteasome Substrates
Norbury, C. C., Basta, S., Donohue, K. B., Tscharke, D. C., Princiotta, M. F., Berglund, P., Gibbs, J., Bennink, J. R., & Yewdell, J. W. (2004) · Science · doi:10.1126/science.1096378 · Cited by 286
Millar, D. G., Garza, K. M., Odermatt, B., Elford, A. R., Ono, N., Li, Z., & Ohashi, P. S. (2003) · Nature Medicine · doi:10.1038/nm962 · Cited by 286
Allen, L.-A. H., & Aderem, A. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80102-6 · Cited by 270
Deussing, J., Roth, W., Saftig, P., Peters, C., Ploegh, H. L., & Villadangos, J. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4516 · Cited by 266
Viral interference with antigen presentation
Yewdell, J. W., & Hill, A. B. (2002) · Nature Immunology · doi:10.1038/ni1102-1019 · Cited by 259
Pozzi, L.-A. M., Maciaszek, J. W., & Rock, K. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2071 · Cited by 259
Self-citationSomersan, S., Larsson, M., Fonteneau, J. F., Basu, S., Srivastava, P., & Bhardwaj, N. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.9.4844 · Cited by 258
Bevan, M. J. (1976) · The Journal of Immunology · doi:10.4049/jimmunol.117.6.2233 · Cited by 254
Biogenesis of phagolysosomes: the 'kiss and run' hypothesis
Desjardins, M. (1995) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)88989-8 · Cited by 252
Rescigno, M., Citterio, S., Thèry, C., Rittig, M., Medaglini, D., Pozzi, G., Amigorena, S., & Ricciardi-Castagnoli, P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5229 · Cited by 251
Cycling of cell-surface MHC glycoproteins through primaquine-sensitive intracellular compartments
Reid, P. A., & Watts, C. (1990) · Nature · doi:10.1038/346655a0 · Cited by 251
Cell-Associated Ovalbumin Is Cross-Presented Much More Efficiently than Soluble Ovalbumin In Vivo
Li, M., Davey, G. M., Sutherland, R. M., Kurts, C., Lew, A. M., Hirst, C., Carbone, F. R., & Heath, W. R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.10.6099 · Cited by 251
Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells
Harding, C. V., Collins, D. S., Slot, J. W., Geuze, H. J., & Unanue, E. R. (1991) · Cell · doi:10.1016/0092-8674(91)90647-h · Cited by 250
Proteases involved in MHC dass II antigen presentation
Villadangos, J. A., Bryant, R. A. R., Deussing, J., Driessen, C., Lennon‐Duménil, A., Riese, R. J., Roth, W., Saftig, P., Shi, G., Chapman, H. A., et al. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01360.x · Cited by 235
ER-mediated phagocytosis: a new membrane for new functions
Desjardins, M. (2003) · Nature Reviews Immunology · doi:10.1038/nri1053 · Cited by 230
Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses
Shi, Y., Zheng, W., & Rock, K. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.260497597 · Cited by 226
Self-citationIn Vivo Cross-Priming of MHC Class I–Restricted Antigens Requires the TAP Transporter
Huang, A. Y. C., Bruce, A. T., Pardoll, D. M., & Levitsky, H. I. (1996) · Immunity · doi:10.1016/s1074-7613(00)80248-4 · Cited by 224
Lennon-Duménil, A.-M., Bakker, A. H., Maehr, R., Fiebiger, E., Overkleeft, H. S., Rosemblatt, M., Ploegh, H. L., & Lagaudrière-Gesbert, C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020327 · Cited by 221
Gao, B., & Tsan, M.-F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303161200 · Cited by 218
Cutting Edge: Heat Shock Protein gp96 Induces Maturation and Migration of CD11c+ Cells In Vivo
Binder, R. J., Anderson, K. M., Basu, S., & Srivastava, P. K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6029 · Cited by 216
Yewdell, J. W., & Haeryfar, S. M. M. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115702 · Cited by 215
Binder, R. J., Blachere, N. E., & Srivastava, P. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011547200 · Cited by 214
Cross-tolerance: A Pathway for Inducing Tolerance to Peripheral Tissue Antigens
Heath, W. R., Kurts, C., Miller, J. F. A. P., & Carbone, F. R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.10.1549 · Cited by 213
Kuppner, M. C., Gastpar, R., Gelwer, S., Nössner, E., Ochmann, O., Scharner, A., & Issels, R. D. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200105)31:5<1602::aid-immu1602>3.0.co;2-w · Cited by 213
Class discrimination in the world of immunology
Bevan, M. J. (1987) · Nature · doi:10.1038/325192b0 · Cited by 211
Rock, K. L., Rothstein, L., Gamble, S., & Fleischacker, C. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.2.438 · Cited by 201
Self-citationDendritic-cell-based therapeutic vaccination against cancer
Nestle, F. O., Farkas, A., & Conrad, C. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.02.003 · Cited by 199
Celluzzi, C. M., & Falo, L. D. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3081 · Cited by 197
A Role for Cathepsin L and Cathepsin S in Peptide Generation for MHC Class II Presentation
Hsieh, C.-S., deRoos, P., Honey, K., Beers, C., & Rudensky, A. Y. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.6.2618 · Cited by 188
Ackerman, A. L., Kyritsis, C., Tampé, R., & Cresswell, P. (2005) · Nature Immunology · doi:10.1038/ni1147 · Cited by 188
Cellular protein is the source of cross-priming antigen in vivo
Shen, L., & Rock, K. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308345101 · Cited by 185
Self-citationSmith, C. M., Belz, G. T., Wilson, N. S., Villadangos, J. A., Shortman, K., Carbone, F. R., & Heath, W. R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4437 · Cited by 182
Antigen Bias in T Cell Cross-Priming
Wolkers, M. C., Brouwenstijn, N., Bakker, A. H., Toebes, M., & Schumacher, T. N. M. (2004) · Science · doi:10.1126/science.1096268 · Cited by 181
Celluzzi, C. M., & Falo, L. D. (1998) · PubMed · Cited by 178
Rock, K. L., Hearn, A. R., Chen, C., & Shi, Y. (2004) · Springer Seminars in Immunopathology · doi:10.1007/s00281-004-0173-3 · Cited by 178
Self-citationCervi, L., MacDonald, A. S., Kane, C., Dzierszinski, F., & Pearce, E. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2016 · Cited by 177
Fully mobilizing host defense: Building better vaccines
Raychaudhuri, S., & Rock, K. L. (1998) · Nature Biotechnology · doi:10.1038/3469 · Cited by 175
Self-citationMazzaccaro, R. J., Gedde, M. M., Jensen, E. R., van Santen, H. M., Ploegh, H. L., Rock, K. L., & Bloom, B. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11786 · Cited by 166
Self-citationBethke, K., Staib, F., Distler, M., Schmitt, U., Jonuleit, H., Enk, A. H., Galle, P. R., & Heike, M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.11.6141 · Cited by 165
Song, R., & Harding, C. V. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.11.4182 · Cited by 162
Heat shock proteins: the ‘Swiss Army Knife’ vaccines against cancers and infectious agents
Srivastava, P. K., & Amato, R. J. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00492-8 · Cited by 161
Overview of vaccine adjuvants: present and future
Hunter, R. L. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00164-0 · Cited by 157
Sigal, L. J., & Rock, K. L. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.8.1143 · Cited by 151
Self-citationNeutrophil Involvement in Cross-Priming CD8+ T Cell Responses to Bacterial Antigens
Tvinnereim, A., Hamilton, S. E., & Harty, J. T. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.1994 · Cited by 151
Rock, K. L., Gamble, S., Rothstein, L., Gramm, C. F., & Benacerraf, B. (1991) · Cell · doi:10.1016/0092-8674(91)90093-e · Cited by 148
Self-citationRuedl, C., Storni, T., Lechner, F., Bächi, T., & Bachmann, M. F. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200203)32:3<818::aid-immu818>3.0.co;2-u · Cited by 147
Effectiveness of Lipid and Lipidophilic Substances as Adjuvants
Dresser, D. W. (1961) · Nature · doi:10.1038/1911169a0 · Cited by 146
Vesicle Size Influences the Trafficking, Processing, and Presentation of Antigens in Lipid Vesicles
Brewer, J. M., Pollock, K. G. J., Tetley, L., & Russell, D. G. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.10.6143 · Cited by 144
Activation of Mammalian Toll-like Receptors by Endogenous Agonists
Johnson, G. B., Brunn, G. J., & Platt, J. L. (2003) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v23.i12.20 · Cited by 143
CpG-DNA Aided Cross-Priming by Cross-Presenting B Cells
Heit, A., Huster, K. M., Schmitz, F., Schiemann, M., Busch, D. H., & Wagner, H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1501 · Cited by 141
Different fates of phagocytosed particles after delivery into macrophage lysosomes.
Oh, Y., & Swanson, J. A. (1996) · The Journal of Cell Biology · doi:10.1083/jcb.132.4.585 · Cited by 141
Ke, Y., & Kapp, J. A. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.3.1179 · Cited by 129
Horwitz, M. S., Ilic, A., Fine, C., Rodriguez, E., & Sarvetnick, N. (2002) · Journal of Clinical Investigation · doi:10.1172/jci11198 · Cited by 120
Shi, Y., & Rock, K. L. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200201)32:1<155::aid-immu155>3.0.co;2-p · Cited by 120
Self-citationHorwitz, M. S., Ilic, A., Fine, C., Rodriguez, E., & Sarvetnick, N. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0211198 · Cited by 110
TAP1‐independent loading of class I molecules by exogenous viral proteins
Bachmann, M. F., Oxenius, A., Pircher, H., Hengartner, H., Ashton‐Rickardt, P. G., Tonegawa, S., & Zinkernagel, R. M. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250637 · Cited by 109
New tools for antigen delivery to the MHC class I pathway
Morón, G., Dadaglio, G., & Leclerc, C. (2003) · Trends in Immunology · doi:10.1016/j.it.2003.11.008 · Cited by 109
Cho, J., Youn, J. W., & Sung, Y. C. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5549 · Cited by 108
Magdalena, M., Kovacsovics‐Bankowski, & Rock, K. L. (1994) · European Journal of Immunology · doi:10.1002/eji.1830241024 · Cited by 105
Self-citationImai, J., Hasegawa, H., Maruya, M., Koyasu, S., & Yahara, I. (2005) · International Immunology · doi:10.1093/intimm/dxh184 · Cited by 103
Sugita, M., & Brenner, M. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.3.1443 · Cited by 95
Lenz, L. L., Butz, E. A., & Bevan, M. J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.8.1135 · Cited by 93
Rock, K. L., & Clark, K. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.10.3721 · Cited by 91
Self-citationGeneration of class I MHC-restricted T-T hybridomas.
Rock, K. L., Rothstein, L., & Gamble, S. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.3.804 · Cited by 83
Self-citationWick, M. J., & Pfeifer, J. D. (1996) · European Journal of Immunology · doi:10.1002/eji.1830261135 · Cited by 79
Grant, E. P., & Rock, K. L. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.1.13 · Cited by 77
Self-citationThe nature of the phagosomal membrane: endoplasmic reticulum versus plasmalemma
Touret, N., Paroutis, P., & Grinstein, S. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.1104630 · Cited by 68
Endogenous neosynthesis vs. cross-presentation of viral antigens for cytotoxic T cell priming
Freigang, S., Egger, D., Bienz, K., Hengartner, H., & Zinkernagel, R. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1835685100 · Cited by 66
Serna, A. N., Ramirez, M. C., Soukhanova, A., & Sigal, L. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.5668 · Cited by 61
Campbell, D., Serwold, T. F., & Shastri, N. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.168 · Cited by 55
Type I interferons promote cross-priming: more functions for old cytokines
Beignon, A., Škoberne, M., & Bhardwaj, N. (2003) · Nature Immunology · doi:10.1038/ni1003-939 · Cited by 53
Phagocytosis and antigen presentation
Watts, C. K. W., & Amigorena, S. (2001) · Seminars in Immunology · doi:10.1006/smim.2001.0334 · Cited by 49
Vigna, J. L., Smith, K. D., & Lutz, C. T. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.10.4503 · Cited by 48
Trafficking of spontaneously endocytosed MHC proteins
Chiu, I. M., Davis, D. M., & Strominger, J. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13944 · Cited by 46
Hori, S., Haury, M., Lafaille, J. J., Demengeot, J., & Coutinho, A. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200212)32:12<3708::aid-immu3708>3.0.co;2-c · Cited by 46
Oh, Y., Harding, C. V., & Swanson, J. A. (1997) · Vaccine · doi:10.1016/s0264-410x(97)00221-1 · Cited by 45
The ins and outs of cross-presentation
Rock, K. L. (2003) · Nature Immunology · doi:10.1038/ni1003-941 · Cited by 42
Self-citationPalliser, D., Guillén, E., Ju, M., & Eisen, H. N. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.1879 · Cited by 34
Alternative processing for MHC class I presentation by immature and CpG‐activated dendritic cells
Chen, L., & Jondal, M. (2004) · European Journal of Immunology · doi:10.1002/eji.200324359 · Cited by 28
Cho, Y., Basta, S., Chen, W., Bennink, J. R., & Yewdell, J. W. (2003) · Journal of Virology · doi:10.1128/jvi.77.8.4679-4684.2003 · Cited by 24
Cited by
Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
Kanzler, H., Barrat, F. J., Hessel, E. M., & Coffman, R. L. (2007) · Nature Medicine · doi:10.1038/nm1589 · Cited by 869
More than one reason to rethink the use of peptides in vaccine design
Purcell, A. W., McCluskey, J., & Rossjohn, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2224 · Cited by 860
Finn, O. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmra072739 · Cited by 774
Macropinocytosis: an endocytic pathway for internalising large gulps
Lim, J. P., & Gleeson, P. A. (2011) · Immunology & Cell Biology · doi:10.1038/icb.2011.20 · Cited by 715
Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo
Villadangos, J. A., & Schnorrer, P. (2007) · Nature Reviews Immunology · doi:10.1038/nri2103 · Cited by 702
Metadata
- Authors
- Rock, K. L., & Shen, L.
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 2005-09-23
- Volume
- 207
- Issue
- 1
- Pages
- 166-183
- ISSN
- 0105-2896 (ISSN-L)
- 1600-065X
- OpenAlex
- W2134250807
- Cited by
- 451
- References
- 157
- FWCI
- 1.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.